Correlates of severity of smoking among persons with severe mental illness

American Journal on Addictions

Volumn 16, Issue 2, 2007, Pages 101-110

  Dixon, Lisa ^a,d   Medoff, Deborah R ^a   Wohlheiter, Karen ^a,b   DiClemente, Carlo ^b   Goldberg, Richard ^a   Kreyenbuhl, Julie ^a   Adams, Curtis ^a   Lucksted, Alicia ^a   Davin, Colleen ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d Department of Psychiatry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; CAUCASIAN; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPIRED AIR; FEMALE; HEALTH CENTER; HUMAN; HYPERTENSION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL DISEASE; MOOD DISORDER; MOUTH DISEASE; QUALITY OF LIFE; SAMPLE SIZE; SCHIZOPHRENIA; SMOKING; STATISTICAL ANALYSIS; SYMPTOM;

ADULT; BRIEF PSYCHIATRIC RATING SCALE; CARBON MONOXIDE; COMORBIDITY; DEMOGRAPHY; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL DISORDERS; PREVALENCE; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; SOMATOFORM DISORDERS;

EID: 34247330930     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490601184415     Document Type: Article

References (59)

1. De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76:135-157.
2. De Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson G. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995;152:453-455.
3. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143:993-997.
4. Shopland DR, Hartman AM, Gibson JT, Mueller MD, Kessler LG, Lynn WR. Cigarette smoking among U.S. adults by state and region: estimates from the current population survey. J Natl Cancer Inst. 1996;88:1748-1758.
5. Tanskanen A, Viinamaki H, Koivumaa-Honkanen HTJ, Juha J. Smoking among psychiatric patients. Eur Psychiatry. 1997;11:179-188.
6. Waxmonsky JA, Thomas MR, Miklowitz DJ, et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the systematic treatment enhancement program. Gen Hosp Psychiatry. 2005;27:321-328.
7. Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry. 1998;155:1490-1501.
8. Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis. 1995;183:559-565.
9. Lyon ER. A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv. 1999;50:1346-1350.
10. Esterberg ML, Compton MT. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med. 2005;61:293-303.
11. Forchuk C, Norman R, Malla A, et al. Schizophrenia and the motivation for smoking. Perspect Psychiatr Care. 2002;38:41-49.
12. Patkar AA, Gopalakrishnan R, Lundy A, Leone FT, Certa KM, Weinstein SP. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis. 2002;190:604-610.
13. Lucksted A, Dixon LB, Sembly JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatr Serv. 2000;51:1544-1548.
14. Leonard S, Adams C, Breese CR, et al. Nicotinic receptor function in schizophrenia. Schizophr Bull. 1996;22:431-445.
15. McEvoy JP, Allen TB. The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Curr Drug Targets CNS Neurol Disord. 2002;1:433-442.
16. Taiminen TJ, Salokangas RK, Saarijarvi S, et al. Smoking and cognitive deficits in schizophrenia: a pilot study. Addict Behav. 1998;23:263-266.
17. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004;29:1067-1083.
18. Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrrenic patients in Nithsdale, Scotland. Am J Psychiatry. 1999;156:1751-1757.
19. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA. 2005;294:1505-1510.
20. Himelhoch S, Moates A, Lehman A, Dixon L. Racial differences in rates and patterns of smoking exist among individuals with serious mental illness. J Assoc Acad Minor Phys. 2005;16:43-50.
21. Stellman SD, Chen Y, Muscat JE, et al. Lung cancer risk in white and black Americans. Ann Epidemiol. 2003;13:294-302.
22. Hahn LP, Folsom AR, Sprafka JM, Norsted SW. Cigarette smoking and cessation behaviors among urban blacks and whites. Public Health Rep. 1990;105:290-295.
23. Wagenknecht LE, Cutter GR, Haley NJ, et al. Racial differences in serum cotinine levels among smokers in the coronary artery risk development in (young) adults study. Am J Public Health. 1990;80:1053-1056.
24. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 1994;45:204-206.
25. Aguilar MC, Gurpegui M, Diaz F, De Leon J. Nicotine dependence and symptoms of schizophrenia. Br J Psychiatry. 2005;186:215-221.
26. de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Does clozapine decrease smoking? Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:757-762.
27. DHHS. U.S. Department of Health and Human Services, National Center for Health Statistics: The third national health and nutrition examination survey 1988-94 (NHANES III). Hyattsville, Md.: Center for Disease Control and Prevention; 1998.
28. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction. 1991;86:1119-1127.
29. DiClemente CC. Addiction and Change: How Addictions Develop and Addicted People Recover. New York: Guilford Press; 2003.
30. DiClemente CC, Schlundt D, Gemell L. Readiness and stages of change in addiction treatment. Am J Addict. 2004;13:103-119.
31. Bedfont Scientific U. EC50 Microl III Smokerlyzer Breath Carbon Monoxide Monitor. Medford, New Jersey, USA.
32. Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J. 1980;281:484-485.
33. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59:295-304.
34. Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce J. Distribution of smokers by stage in three representative samples. Prev Med. 1995;24:401-411.
35. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-1907.
36. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;10:1121-1123.
37. Hays RD, Merz JF, Nicholas R. Response burden, reliability, and validity of the CAGE, short MAST, and AUDIT alcohol screening measures. Behav Res Methods Instrum Comput. 1995;27:277-280.
38. Perkins D, Stroup TS, Lieberman JA. Psychotic disorders measures. In: Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association Press; 2000:485-513.
39. Cohen S, Kamarack T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:31-67.
40. Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Scacapan S, Oskamp S, eds. The Social Psychology of Health. Newbury Park, Calif.: Sage; 1988:31-67.
41. Lehman AF. A quality of life interview for the chronically mentally ill. Evaluation and Program Planning. 1988;11:51-62.
42. Maurice E, Trosclain A, Merritt R, Caraballo R, Malarcher A, Husten C, Pechacek T. "Cigarette Smoking Amoung Adults-United States," 2004. MMWR Weekly. 2005;54:1121-1124.
43. Murray RP, Connett JE, Buist AS, Gerald LB, Eichenhorn MS. Experience of black participants in the lung health study smoking cessation intervention program. Nicotine Tob Res. 2001;3:375-382.
44. Perez-Stable EJ, Herrera B, Jacob PI, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280:152-156.
45. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. an update. Clin Pharmacokinet. 1999;36:425-438.
46. Caraballo RS, Giovino GA, Pechacek TF, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: third national health and nutrition examination survey 1988-1991. JAMA. 1998;280:135-139.
47. Avila MT, Sherr JD, Hong E, Myers CS, Thaker GK. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia. Neuropsychopharmacology. 2003;28:2184-2191.
48. Depatie L, O'Driscoll GA, Holahan AL, et al. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebocontrolled, cross-over study. Neuropsychopharmacology. 2002;27:1056-1070.
49. Myers CS, Robles O, Kakoyannis AN, et al. Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl). 2004;174:334-340.
50. Olincy A, Johnson LL, Ross RG. Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Res. 2003;117:223-236.
51. Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354:333-342.
52. Hatsukami DK, Kotlyar M, Allen S, et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128:2528-2537.
53. Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen centre for prospective population studies. Am J Epidemiol. 2002;156:994-1001.
54. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809-1820.
55. Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 2005;41:244-260.
56. Porter JA, von Fraunhofer JA. Success or failure of dental implants? A literature review with treatment considerations. Gen Dent. 2005;53:423-432.
57. Andrews JA, Severson HH, Lichtenstein E, Gordon JS. Relationship between tobacco use and self-reported oral hygiene habits. J Am Dent Assoc. 1998;129:313-320.
58. Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003;41:560-570.
59. Ziedonis D, Williams JM, Smelson DS. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003;326:223-230.